Eli Lilly Shares Seen Rising 18% as Profits Surge

Eli Lilly and Co.'s (LLY) stock may be set to rise by over 18% if analysts price targets prove to be correct. Analysts have been upping their estimates of the pharmaceutical company in recent weeks, at a much faster pace than peers like Merck & Co., Inc. (MRK), Pfizer Inc. (PFE) and Bristol-Myers Squibb Co. (BMY).